Mumbai: The India’s largest airline by marketshare, Jet Airways will get 20 more 
New Delhi: Liquor tycoon Vijay Mallya has finished the 90 million euro transaction 
, a wholly owned subsidiary of New Brunswick-based Johnson & Johnson has reported that
Chicago: Several Kentucky regions has filed suit against the manufacturers of the stroEvoplay, a renowned force in online casino game development, has officially entered the Azerbaijani market through a pivotal partnership with Azerlotereya OJSC, the state-owned lottery operator.
News in Focus
The African iGaming market is entering a new era of innovation and competitiveness as two notable industry forces—Booming Games and Bitville Gaming—join hands to accelerate digital transformation a
In an era where digital leisure has eclipsed traditional modes of entertainment, the online betting ecosystem has surged ahead, blending innovation, accessibility, and regulatory adaptation.
Kotak Institutional Equities has issued a BUY recommendation on InterGlobe Aviation (IndiGo), underscoring the carrier’s strategic prowess in capacity planning, international expansion, and differe
Motilal Oswal Financial Services has issued a BUY recommendation on JK Cement, underlining the company’s robust operational execution and ambitious expansion agenda.
Kotak Institutional Equities has issued a BUY Call on Tata Consultancy Services (TCS), maintaining a fair value target of Rs3,800 per share.
Main Regional Stories
IREDA share price will be in focus on Friday as the PSU energy development major has declared quarterly results. IREDA has been trading firm over the last few sessions and the stock managed to closed around Rs 170 on Thursday.
Maruti Suzuki, Tata Steel, Bajaj Finance, Jio Financial Services and Tata Motors were among major gainers on NSE Nifty on Thursday. Overall market trend was bearish and NSE Nifty 50 closed the session with 120 points loss.
Featured, Analyst View, CRISPR Therapeutics, Morningstar Research, Pharmaceutical Sector, Switzerland
Morningstar has issued a BUY recommendation on CRISPR Therapeutics AG (NASDAQ: CRSP), underscoring the stock’s significant undervaluation and robust long-term prospects, in its latest research report dated July 9, 2025.
IndusInd Bank, Bajaj Finserv and Jio Financial Services were among major gainers in today's session with IndusInd Bank trading 1.6 percent higher.
